EcoDrugPlus

Ileal Sodium/bile Acid Cotransporter-Like

Ensembl ID : ENSCVAG00000008525
Gene Symbol: LOC107082484
3 Cross references
210 Possible Orthologues:

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1-Like

Ensembl ID : ENSCVAG00000018992
Gene Symbol: LOC107084596
3 Cross references
212 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSCVAG00000018660
Gene Symbol: IKBKB
3 Cross references
198 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSCVAG00000010586
Gene Symbol: IMPDH1
4 Cross references
259 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSCVAG00000003632
Gene Symbol: IMPDH2
4 Cross references
202 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b

Ensembl ID : ENSCVAG00000017253
Gene Symbol: LOC107101173
4 Cross references
258 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSCVAG00000015388
Gene Symbol: INPP5D
3 Cross references
216 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSCVAG00000001296
Gene Symbol: IGF1R
3 Cross references
204 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSCVAG00000002588
Gene Symbol: IGF1R
3 Cross references
206 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSCVAG00000018467
Gene Symbol: INSR
3 Cross references
230 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSCVAG00000021557
Gene Symbol: LOC107100834
3 Cross references
201 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSCVAG00000014704
Gene Symbol: LOC107091914
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).